Contact

For inquiries regarding the utilization of ethnobotanicals, or in case you are experiencing an adverse situation or difficulty integrating and experience, please read this page. For inquiries regarding legal support , please read this page.

  • We don鈥檛 offer sessions of ayahuasca or iboga.
  • We don鈥檛 recommend centers or people who perform/do sessions.

    map mapa marcador ICEERS

    Office

    Carrer de Sep煤lveda, 65 , Oficina 2, 08015 Barcelona Espa帽a +34 931 88 20 99
    esteroides anab贸lico androg茅nicos reducci贸n riesgos anabolic androgenic steroids risk reduction

    Anabolic-Androgenic Steroids and Analogue Substances

    15.06.2013

    Anabolic-androgenic steroids and analogue substances

    Authors:
    Jos茅 Carlos Bouso, and Fernando Caudevilla.

    Book:
    De riesgos y placeres: manual para entender las drogas

    Year:
    2013

     

    About the study

    This study represents chapter number 30 of the book De riesgos y placeres: manual para entender las drogas (Of Risks and Pleasures: A Manual for Understanding Drugs). Anabolic-androgenic steroids (AASs) are a group of drugs synthetically derived from testosterone, a natural male hormone, that exhibit anabolic (muscle building) and androgenic (masculinizing) effects, with different potency for each effect depending on the product.

    An important aspect when assessing the use of AASs from a risk reduction perspective is access to information, the quality of which is highly variable and, in general, much lower than that offered by websites and forums on recreational drugs.

    The development of reliable information systems based on scientific evidence, the involvement of professionals and the extension of testing programs to anabolic-androgenic steroids may be some of the risk reduction strategies that should be applied to these substances.

     

    Excerpt

    “Most people who are introduced to the use of AASs will never develop an addiction. But people who report significant concerns regarding their muscularity, and especially people with ‘muscle dysmorphia’ (popularly known as vigorexia) are particularly likely to initiate anabolic use and exhibit problematic patterns of use (Peterson, Bengtsson, Voltaire-Carlsson, & Thibin, 2010). A study of 233 male AAS users weightlifters recruited from fitness centers in Florida and California found that adolescent behavioral disorders, accompanied by intense preoccupation with muscularity and body image, may be risk factors for youthful initiation of AAS use in weightlifters aiming for muscle strengthening (Pope, Kanayama, & Hudson, 2012). 
     
    Although most users do not undergo more than 12 cycles in their lifetime, there is a percentage of around 30% who maintain an almost continuous pattern of consumption despite the adverse medical, psychological and social effects they may experience, meeting psychiatric criteria (DSM-IV) of dependence. Hence the term AAS dependence (Kanayama, Brower, Wood, Hudson, & Pope, 2009). The prevalence of AAS dependence in women is minimal.”

     

    Link to the article

     

    Contact ICEERS Research team

     
    Photo by Norbert Buduczki on Unsplash.

    Categories: Studies & papers , Others
    Tags: scientific research , study , adverse effects , risk reduction , risks , harm reduction , steroids , book chapter